Evaluation of distal symmetric polyneuropathy: The role of autonomic testing, nerve biopsy, and skin biopsy (an evidence‐based review)

Abstract

Distal symmetric polyneuropathy (DSP) is the most common variety of neuropathy. Since the evaluation of this disorder is not standardized, the available literature was reviewed to provide evidence-based guidelines regarding the role of autonomic testing, nerve biopsy, and skin biopsy for the assessment of polyneuropathy. A literature review using MEDLINE, EMBASE, Science Citation Index, and Current Contents was performed to identify the best evidence regarding the evaluation of polyneuropathy published between 1980 and March 2007. Articles were classified according to a four-tiered level of evidence scheme and recommendations were based on the level of evidence. (1) Autonomic testing may be considered in the evaluation of patients with polyneuropathy to document autonomic nervous system dysfunction (Level B). Such testing should be considered especially for the evaluation of suspected autonomic neuropathy (Level B) and distal small fiber sensory polyneuropathy (SFSN) (Level C). A battery of validated tests is recommended to achieve the highest diagnostic accuracy (Level B). (2) Nerve biopsy is generally accepted as useful in the evaluation of certain neuropathies as in patients with suspected amyloid neuropathy, mononeuropathy multiplex due to vasculitis, or with atypical forms of chronic inflammatory demyelinating polyneuropathy (CIDP). However, the literature is insufficient to provide a recommendation regarding when a nerve biopsy may be useful in the evaluation of DSP (Level U). (3) Skin biopsy is a validated technique for determining intraepidermal nerve fiber (IENF) density and may be considered for the diagnosis of DSP, particularly SFSN (Level C). There is a need for additional prospective studies to define more exact guidelines for the evaluation of polyneuropathy.

Peripheral neuropathies in Sjögren’s syndrome: A critical update on clinical features and pathogenetic mechanisms

“…The most reliable test is the skin biopsy that objectively measures the intraepidermal nerve fiber density. This is a simple outpatient procedure which, when standardized, can accurately diagnose SFN [48,49]. Sural nerve biopsy is not useful and is not recommended.…”

Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies

“…These techniques are also helping us to look more closely at the pathophysiology of neurotoxicity and point us in the direction of better treatments [25]. Another interesting assessment method for CIN is skin biopsy [26][27][28][29]. It allows the unmyelinated small nervous fi bres that lie in the epidermis to be seen and quantifi ed in vivo.…”

Actividad espontánea de nociceptores cutáneos en pacientes con neuropatía de fibras delgadas

“…El mecanismo de esta SCP no es del todo claro pero podría corresponder a una sensibilización de nociceptores 18 o a la expresión de aferentes sensibles al frío y mentol con pérdida de los aferentes A delta 11 . Otros métodos diagnósticos de neuropatía de fibras delgadas como los estudios de función autonómica y la biopsia cutánea con cuantificación de la densidad de fibras epidérmi-cas son complementarios y han sido validadas en múltiples estudios 14,19 . La microneurografía, desarrollada en Suecia y Alemania a fines de la década 1960-69, es una herramienta de mucho valor en la comprensión de la función de aferentes delgados en sujetos normales 5 , así como en la detección de anomalías funcionales en pacientes con neuropatía dolorosa [20][21][22] .…”